161 related articles for article (PubMed ID: 38897882)
1. Beyond insulin: Unraveling the complex interplay of ER stress, oxidative damage, and CFTR modulation in CFRD.
Umashankar B; Eliasson L; Ooi CY; Kim KW; Shaw JAM; Waters SA
J Cyst Fibros; 2024 Jun; ():. PubMed ID: 38897882
[TBL] [Abstract][Full Text] [Related]
2. Islet-intrinsic effects of CFTR mutation.
Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.
Hasan S; Soltman S; Wood C; Blackman SM
J Clin Transl Endocrinol; 2022 Mar; 27():100287. PubMed ID: 34976741
[TBL] [Abstract][Full Text] [Related]
4. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
[TBL] [Abstract][Full Text] [Related]
5. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
[TBL] [Abstract][Full Text] [Related]
6. CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.
Ntimbane T; Mailhot G; Spahis S; Rabasa-Lhoret R; Kleme ML; Melloul D; Brochiero E; Berthiaume Y; Levy E
Am J Physiol Endocrinol Metab; 2016 Feb; 310(3):E200-12. PubMed ID: 26625901
[TBL] [Abstract][Full Text] [Related]
7. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
Barrio R
Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous expression of CFTR in insulin-secreting β-cells of the normal human islet.
Di Fulvio M; Bogdani M; Velasco M; McMillen TS; Ridaura C; Kelly L; Almutairi MM; Kursan S; Sajib AA; Hiriart M; Aguilar-Bryan L
PLoS One; 2020; 15(12):e0242749. PubMed ID: 33264332
[TBL] [Abstract][Full Text] [Related]
9. The role of modulators in cystic fibrosis related diabetes.
Merjaneh L; Hasan S; Kasim N; Ode KL
J Clin Transl Endocrinol; 2022 Mar; 27():100286. PubMed ID: 34917484
[TBL] [Abstract][Full Text] [Related]
10. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
11. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
12. Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.
Westholm E; Wendt A; Eliasson L
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211031204. PubMed ID: 34345195
[TBL] [Abstract][Full Text] [Related]
13. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
14. Survival in a bad neighborhood: pancreatic islets in cystic fibrosis.
Norris AW; Ode KL; Merjaneh L; Sanda S; Yi Y; Sun X; Engelhardt JF; Hull RL
J Endocrinol; 2019 Feb; ():. PubMed ID: 30759072
[TBL] [Abstract][Full Text] [Related]
15. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
Hasan S; Khan MS; Lansang MC
J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
[TBL] [Abstract][Full Text] [Related]
16. Cystic Fibrosis-Related Diabetes.
Kayani K; Mohammed R; Mohiaddin H
Front Endocrinol (Lausanne); 2018; 9():20. PubMed ID: 29515516
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
[TBL] [Abstract][Full Text] [Related]
18. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
[TBL] [Abstract][Full Text] [Related]
19. Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.
Yoon JC
J Endocr Soc; 2017 Nov; 1(11):1386-1400. PubMed ID: 29264462
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes.
Al-Selwi Y; Shaw JA; Kattner N
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211048813. PubMed ID: 34675737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
